CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3.
Mei MeiYingjun WangWenting SongZhaoming LiQilong WangJiayin LiMingzhi ZhangPublished in: Cancer cell international (2021)
CircADARB1 was highly expressed in NKTCL plasma and circADARB1 was a potential biomarker to assist diagnosis and predict the response in NKTCL. CircADARB1 bound up to miR-214-3p and regulated p-Stat3.